97826243 - OPTIDC

Information

• Trademark
• 97826243

• Source

• Serial Number

  97826243

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 35 - Advertising
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  March 07, 2023
  a year ago

• Transaction Date

  December 10, 2024
  2 days ago

• Status Date

  December 10, 2024
  2 days ago

• Published for Opposition Date

  December 10, 2024
  2 days ago

• Location Date

  November 20, 2024
  22 days ago

• Status Code

  686

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  PAINTER, VALERIYA

• Attorney Docket Number

  5886.151685

  Attorney Name

  Amy C. Ziegler

  Law Office Assigned Location Code

  O20

• Owners

  • Sichuan Kelun-Biotech BiopharmaceuticalCo., Ltd.
  • Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Case File Statements

• GS0051: Medicines for human purposes, namely, medicines for the treatment of cardiovascular disease, coronary heart disease, angina pectoris, myocarditis, cardiac arrhythmia, tumor, autoimmune disease, blood disease, mental illness, ophthalmic, metabolic diseases and disorders in the nature of diabetes, kidney diseases, osteoporosis; Medicines for human purposes, namely, biological products, prepared by using biological materials in the nature of cultures of microorganisms for medical use, cells for medical purposes, and various animal and human biological tissues and liquids cultures for medical or veterinary purposes, obtained by genetic engineering, cell engineering, protein engineering, fermentation engineering for the treatment of central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, antipyretic and analgesic purposes, non-steroidal anti-inflammatory purpose, infectious diseases, autoimmune diseases, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes; Medicines for human purposes, namely, parenteral nutritional supplement; anti-viral medicines; medicines for alleviating constipation; Anaesthetics; Bacterial poisons; Coated capsule medicines, for prevention and treatment of human diseases, namely, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, antipyretic and analgesic purposes, non-steroidal anti-inflammatory purpose, infectious diseases, autoimmune diseases, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes; Empty capsules for pharmaceuticals in the nature of hard capsules, soft capsules, enteric capsules, Microcapsule, drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals, delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements, coated capsule medicines used for parenteral nutrition supplement; Pharmaceutical preparations for the treatment of cardiovascular pharmaceutical preparations; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for reducing cholesterol; Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases and arthritis; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; Pharmaceutical preparation for treating microbial diseases, namely, antibiotic; Pharmaceutical preparations for the treatment of mental illness and ophthalmic disease; Pharmaceutical preparations for contrast agent, infectious disease, blood disease and kidney disease; Pharmaceutical preparations containing chemical drugs and biological products for the prevention and treatment of central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, infectious diseases, autoimmune diseases; Pharmaceutical preparations containing chemical drugs and biological products for antipyretic and analgesic purposes, non-steroidal anti-inflammatory purpose, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes and parenteral nutrition purposes; chemico-pharmaceutical preparations for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases; chemico-pharmaceutical preparations for relief from asthma and coughs; chemico-pharmaceutical preparations for parenteral nutrition purposes, antipyretic and analgesic purposes, non-steroidal anti-inflammatory purpose, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes; Vaccines; Analgesics; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune disease; drugs for medical purposes, namely, pharmaceutical preparations for relief from asthma and coughs; drugs for medical purposes, namely, pharmaceutical preparations for parenteral nutrition purposes, antipyretic and analgesic purposes, non-steroidal anti-inflammatory purpose, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes; Medicinal tea; Tranquilizer; Hormones for medical purposes; Yeast for pharmaceutical purposes; general anesthetics; anti-inflammatory ointments; anti-itch ointments; antibiotic ointments; herbal anti-itch ointments for pets; ointments for sunburn; cachets for pharmaceutical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for the treatment of anemia, cancer, cardiovascular system diseases, and for relief from asthma and coughs, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, parenteral nutrition, antipyretic and analgesic purposes, non-steroidal anti-inflammatory purpose, infectious disease, autoimmune disease, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes; empty cachets for pharmaceuticals in the nature of hard cachets, soft cachets, enteric cachets, microcachets; drug delivery agents in the form of cachets, namely, drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; phosphates for pharmaceutical purposes, namely, glycerophosphates, calcium supplements; Tranquillizers; sterilizing preparations; Styptic preparations; Sugar for medical purposes; Acetates for pharmaceutical purposes, namely, calcium channel blockers, Aluminum acetate, calcium acetate, pharmaceuticals used in dialysis; Biological preparations for use in cell cultures for medical purposes; Medical preparations for slimming purposes; chemical preparations for pharmaceutical purposes, all used for treatment of anemia, cardiovascular system diseases, deaden pain, and relieving asthma and coughs; biochemical preparations for the treatment of tumors and cardiovascular system diseases; chemical conductors for electrocardiograph electrodes; paper chemically treated for diagnostic use in the detection of fecal occult blood; Glucose for medical purposes; Iodides for pharmaceutical purposes, namely, iodine, iodoform, alkaline iodides for pharmaceutical purposes, mineral salts for medical purposes; Antibiotics; Stem cells for medical purposes; Biological tissue cultures for medical purposes; Slimming pills; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for human use for the prevention of solid organ transplant rejection; pharmaceutical preparations for transplantation and transplant-related conditions affecting the kidney; bone graft materials derived from human tissue; processed human donor skin for the replacement of soft tissue; surgical mesh comprised primarily of living tissue, and ex vivo cells being immune cells, red blood cells, T cells, NK cells, islet cells; Collagen for medical purposes; Plant extracts for pharmaceutical purposes; Preparations of microorganisms for medical or veterinary use; Pharmaceutical injection preparations, namely, injection for pharmaceutical purposes for the treatment of, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, parenteral nutrition, infectious disease, autoimmune disease, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes; allergy tablets; antibiotic tablets; sleeping tablets; vitamin tablets; tablets comprise chemicals, biological products and blood products for the treatment of tumors; oral tablets, lozenge, sublingual tablets, oral patches, chewable tablets, dispersible tablets, effervescent tablets, vaginal tablets, immediate and sustained release and controlled release tablets and enteric coated tablets, all for the treatment of tumors; tincture of iodine for medical purposes; topical anesthetics; topical analgesics; topical first aid gels; topical gel for treatment of scars; raw material medicine, namely, medicinal preparations in raw material form used for the treatment of tumor, asthma, and chest congestion; official Chinese traditional medicinal herbs; Enzymes, amino acids, nucleotides, and antibodies all for medical purposes; Protein preparations for the treatment of cancer, autoimmune disease, tumor purposes; Synthetic peptide preparations for the treatment of cancer, autoimmune disease, tumor purposes; amino acid preparations comprising of amino acid derivatives for the treatment of cancer, autoimmune disease, tumor purposes; polysaccharide preparations for the treatment of cancer, autoimmune disease, tumor purposes; nucleotide preparations comprising of nucleotide derivatives for the treatment of cancer, autoimmune disease, tumor purposes; lipid peptide preparations for the treatment of cancer, autoimmune disease, tumor purposes; coenzyme preparations for the treatment of cancer, autoimmune disease, tumor purposes; Biochemical reagents for medical or veterinary purposes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; test strips for measuring blood glucose levels; blood for medical purposes; blood plasma; blood substitutes for human and veterinary use; cord blood for medical purposes; cord blood for veterinary purposes; blood preparations for medical purposes, namely, human albumin, human placental albumin, intravenous immunoglobulin, intramuscular immunoglobulin, histamine human immunoglobulin, specific immunoglobulin, hepatitis B immunoglobulin, rabies immunoglobulin, tetanus immunoglobulin, human coagulation factor VIII, human prothrombin complex, human fibrinogen, lymphocyte immunoglobulin; processed blood for medicinal or therapeutic purposes; Diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; Radiological contrast substances for medical purposes; Bacteriological Mediums for medical purposes or veterinary purposes; Media for bacteriological cultures; Nutritive substances for microorganisms for medical purposes; dietetic substances consisting of vitamins, minerals, amino acids and trace elements; amino acid dietary supplements; vitamin and mineral food supplements; Yeast dietary supplements; laxatives for veterinary purposes; pain relief medication for veterinary purposes; Biological preparations veterinary purposes for respiratory and reproductive diseases in cattle; Biological preparations for veterinary purposes for the treatment of arthritis, muscle soreness and sprains; Biological preparations for veterinary purposes for the treatment of bacterial infections in dogs; Biological preparations for veterinary purposes for the treatment of infectious diseases, namely, respiratory infections, eye infections, topical infections; Biological preparations for veterinary purposes for the treatment of infectious diseases, namely, swine dysentery, bacterial enteritis, bluecomb, pneumonia; Biological preparations for veterinary purposes for the treatment of vitamin deficiencies; Biological preparations for veterinary purposes for the treatment of intestinal bacteria; Biological preparations for veterinary purposes for the treatment of tumors; Veterinary pharmaceutical preparations for respiratory and reproductive diseases in cattle; veterinary pharmaceutical preparations for the treatment of arthritis, muscle soreness and sprains; veterinary pharmaceutical preparations for the treatment of bacterial infections in dogs; veterinary pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections, topical infections; veterinary pharmaceutical preparations for the treatment of infectious diseases, namely, swine dysentery, bacterial enteritis, bluecomb, pneumonia; veterinary pharmaceutical preparations for the treatment of vitamin deficiencies; veterinary preparations for treatment of intestinal bacteria; veterinary preparations for veterinary purposes for the treatment of tumors
• GS0351: Import-export agency services; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Retail store and wholesale distributorship services for pharmaceuticals; Retail store and wholesale store services for pharmaceutical preparations; Retail store and wholesale store services for sanitary preparations; Retail store and wholesale store services for medical supplies; Retail store and wholesale store services for veterinary medicine; Retail store and wholesale store services for veterinary preparations
• GS0011: Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use, polynucleotides for in vitro and in vivo scientific and research purposes, polypeptides for in vitro research use, precursors for in vitro genetic engineering use, and biochemicals for in vitro and in vivo scientific use; Raw material medicine, namely, active chemical ingredients for use in the manufacture of anti-tumor, anti-cancer, anti-infective, and antiviral medications; Raw material medicine, namely, active chemical ingredients for use in the manufacture of medications treating cardiovascular diseases, autoimmune disorders, infectious diseases, hematological disorders, mental health disorders, eye diseases, metabolic diseases, renal disorders, inflammatory conditions, microbial infections, and osteoporosis; Raw material medicine, namely, active chemical ingredients for use in the manufacture of contrast media and parenteral nutrition formulations; Raw material medicine, namely, active chemical ingredients for use in the manufacture of medications aimed at lowering cholesterol, reducing blood glucose, promoting diuresis, and providing antipyretic and analgesic effects; Raw material medicine, namely, active chemical ingredients for use in the manufacture of therapies and preventatives for central and peripheral nervous system disorders, circulatory system diseases, and gastrointestinal disorders; Raw material medicine, namely, protein in raw material form for scientific and medical research; Acetates for pharmaceutical purposes, namely, Methyl acetate, Lead acetate, Acetates, Butyl acetate, Octyl acetate, Amyl acetate, Vinyl acetate, Lime acetate, Zinc acetate, Acetate of cellulose, unprocessed, Cobalt acetate, Manganese acetate and potassium acetate; Phosphates for pharmaceutical purposes, namely, Dibasic potassium phosphate, Calcium phosphate, Ammonium phosphate, Sodium phosphate, Sodium aluminum phosphate, Copper phosphate, Magnesium phosphate, Lithium phosphate, Iron phosphate, Barium phosphate, Boron phosphate, Manganese phosphate, Potassium phosphate, Phosphates, Zinc phosphate, Phosphoric anhydride, and Phosphoric acid
• GS0441: Hospital services; Health care services, namely, medical and mental health therapy services; Medical assistance; Pharmaceutical advice; Telemedicine services; medical and mental health therapy services; Alternative medicine services; Convalescent home services
• GS0101: Needles for medical purposes; Syringes for injections; Probes for medical purposes; Dropper bottles for medical purposes for administering medication, sold empty; Hypodermic syringes; Medical fluid injectors for medical purposes; vaporizers for medical purposes; Medical apparatus and instruments, namely, cups for dispensing medicine, disposable hypodermic syringes for medical use, syringes for medical purposes; medical apparatus and instruments used for diagnosis, monitoring, and treatment purposes of vital signs, blood pressure, heart rate, blood properties and respiratory events, tumor, and cardiovascular disease; medical apparatus for introducing pharmaceutical preparations into the human body; medical apparatus for facilitating the inhalation of pharmaceutical preparations; Syringes for medical purposes; Dialyzers; Injection instruments without needles
• GS0421: Genetic testing for scientific research purposes; Medical research services; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development of vaccines and medicines; Zoological research services; Technical research in the field of technical pharmaceutical studies; Scientific Laboratory services; Research and development of new products for others; Chemical analysis; Chemistry services being chemistry consultation, research, and development services in the field of chemistry; Chemical research, namely, research in the field of chemistry; Cosmetic research; Biological research; Scientific research in the nature of conducting clinical trials for others in the field of anti-tumor, anti-cancer, anti-infection, and anti-viral drugs; Scientific research in the nature of conducting clinical trials for others in the field of cardiovascular diseases, autoimmune diseases, infectious diseases, hematologic disorders, psychiatric disorders, ophthalmic conditions, metabolic disorders, renal diseases, inflammatory conditions, microbial infections, and osteoporosis; Scientific research in the nature of conducting clinical trials for others in the field of contrast agents and parenteral nutrition; Scientific research in the nature of conducting clinical trials for others in the field of cholesterol-lowering drugs, blood sugar-lowering drugs, diuretics, and antipyretic analgesics; Scientific research in the nature of conducting clinical trials for others in the field of central nervous system disorders, peripheral nervous system disorders, circulatory system disorders, and digestive system disorders

Case File Event Statements

• 3/10/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 3/27/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 12/5/2023 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 12/5/2023 - a year ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/5/2023 - a year ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/5/2023 - a year ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/4/2024 - 9 months ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/4/2024 - 9 months ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/4/2024 - 9 months ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/17/2024 - 7 months ago

  10 - FINAL REFUSAL WRITTEN Type: CNFR

• 4/17/2024 - 7 months ago

  11 - FINAL REFUSAL E-MAILED Type: GNFR

• 4/17/2024 - 7 months ago

  12 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 7/11/2024 - 5 months ago

  16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 7/11/2024 - 5 months ago

  17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/11/2024 - 5 months ago

  13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 7/11/2024 - 5 months ago

  15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 7/11/2024 - 5 months ago

  14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 7/30/2024 - 4 months ago

  18 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 8/14/2024 - 4 months ago

  20 - ASSIGNED TO EXAMINER Type: DOCK

• 8/14/2024 - 4 months ago

  19 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 8/26/2024 - 3 months ago

  23 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/26/2024 - 3 months ago

  22 - NON-FINAL ACTION E-MAILED Type: GNRT

• 8/26/2024 - 3 months ago

  21 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/24/2024 - 2 months ago

  25 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 9/24/2024 - 2 months ago

  26 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 9/24/2024 - 2 months ago

  24 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 9/24/2024 - 2 months ago

  27 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 11/15/2024 - 27 days ago

  30 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 11/15/2024 - 27 days ago

  29 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 11/15/2024 - 27 days ago

  32 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/15/2024 - 27 days ago

  31 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 11/15/2024 - 27 days ago

  28 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 12/4/2024 - 8 days ago

  33 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 12/10/2024 - 2 days ago

  34 - PUBLISHED FOR OPPOSITION Type: PUBO

• 12/10/2024 - 2 days ago

  35 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB